Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiling Lu

Showing results (181-190 of 224) with videos related to

Pageof 23
Sort By:
Plos One|October 12, 2017
Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast CancerJames E Korkola, Eric A Collisson, Laura M Heiser, et al.
Cancer Cell|October 7, 2015
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human CancersLeng Han, Lixia Diao, Shuangxing Yu, et al.
Cell Reports|August 22, 2019
Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic ReprogrammingRaquel Buj, Chi-Wei Chen, Erika S Dahl, et al.
Cancer Cell|February 16, 2017
Characterization of Human Cancer Cell Lines by Reverse-phase Protein ArraysJun Li, Wei Zhao, Rehan Akbani, et al.
Genome Research|October 3, 2012
Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancerHan Liang, Lydia W T Cheung, Jie Li, et al.
Cell Reports|December 26, 2019
miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast CancerDeepak Parashar, Anjali Geethadevi, Miriam Ragle Aure, et al.
Cancer Immunology Research|April 9, 2020
Verteporfin Inhibits PD-L1 through Autophagy and the STAT1-IRF1-TRIM28 Signaling Axis, Exerting Antitumor EfficacyJiyong Liang, Lulu Wang, Chao Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in GliomasShiyou Wei, Delong Yin, Shengnan Yu, et al.
Cancer Cell|November 6, 2020
Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell LinesWei Zhao, Jun Li, Mei-Ju M Chen, et al.
Cancer Cell|June 12, 2019
Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining EfficacyYong Fang, Daniel J McGrail, Chaoyang Sun, et al.
Pageof 23

Showing results (181-190 of 224) with videos related to

Sort By:
Pageof 23
Plos One|October 12, 2017
Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast CancerJames E Korkola, Eric A Collisson, Laura M Heiser, et al.
Cancer Cell|October 7, 2015
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human CancersLeng Han, Lixia Diao, Shuangxing Yu, et al.
Cell Reports|August 22, 2019
Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic ReprogrammingRaquel Buj, Chi-Wei Chen, Erika S Dahl, et al.
Cancer Cell|February 16, 2017
Characterization of Human Cancer Cell Lines by Reverse-phase Protein ArraysJun Li, Wei Zhao, Rehan Akbani, et al.
Genome Research|October 3, 2012
Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancerHan Liang, Lydia W T Cheung, Jie Li, et al.
Cell Reports|December 26, 2019
miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast CancerDeepak Parashar, Anjali Geethadevi, Miriam Ragle Aure, et al.
Cancer Immunology Research|April 9, 2020
Verteporfin Inhibits PD-L1 through Autophagy and the STAT1-IRF1-TRIM28 Signaling Axis, Exerting Antitumor EfficacyJiyong Liang, Lulu Wang, Chao Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in GliomasShiyou Wei, Delong Yin, Shengnan Yu, et al.
Cancer Cell|November 6, 2020
Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell LinesWei Zhao, Jun Li, Mei-Ju M Chen, et al.
Cancer Cell|June 12, 2019
Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining EfficacyYong Fang, Daniel J McGrail, Chaoyang Sun, et al.
Pageof 23